Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LS Instruments develops and commercializes advanced light scattering-based analytical instruments for particle sizing and contact-free rheology of complex systems such as proteins, viruses, emulsions, microgels, polymers, lipid nanoparticles (LNPs), adeno-associated viruses (AAVs), and other nanomaterials used in pharmaceutical formulation development and academic research.[1][2][3][5] Their technology enables precise characterization even in turbid or highly concentrated samples.
The company's tools are widely used in pharmaceutical R&D—including vaccine formulation—and have been validated through collaborations with leading CRO/CDMOs like Solvias.[1][2][5] They serve customers across academia and industry in over 34 countries.
Recent achievements include breakthroughs in vaccine formulation analytics (notably RNA vaccines) via partnerships with Swiss-based Solvias.[5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LS Instruments.